Status:
COMPLETED
First- or Second- Class Compression Hosiery After Endovenous Laser With Sclerotherapy and Ambulatory Phlebectomy
Lead Sponsor:
Moscow City Hospital named after A.K. Eramishantsev
Collaborating Sponsors:
Pirogov Russian National Research Medical University
Vishnevsky Center of Surgery
Conditions:
Varicose Veins
Chronic Venous Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Investigators hypothesize that first class compression therapy during the postoperative period will improve patient adherence due to easier application and reduced discomfort. Therefore, planning to c...
Detailed Description
In recent decades, significant advancements have emerged in varicose vein treatment. Endovenous laser ablation (EVLA) and radiofrequency ablation (RFA) have become the leading techniques for eliminati...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Varicose veins of the lower extremities (CEAP classification C2-C5)
- Varicose disease in the great saphenous vein (GSV) and its tributaries
- Planned endovenous laser ablation of the GSV trunk with concomitant combined sclerotherapy and phlebectomy of tributaries
- Technical success of intervention (complete ablation of the GSV)
- Signed informed consent for study participation
Exclusion
- Primary reflux outside the GSV trunk
- History of or acute deep vein thrombosis
- Deep vein insufficiency
- GSV recanalization post-intervention
- Clinical class C6 of chronic venous disease (CVD) according to CEAP classification
- Contraindications or limitations for prolonged compression therapy, including but not limited to chronic arterial diseases of the lower extremities (any severity), skin diseases
- Pathological conditions of lower limbs causing non-venous pain
- Use of vasoactive medications within 1 month before/after surgery
- Refusal to participate in the study
Key Trial Info
Start Date :
April 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06913764
Start Date
April 7 2025
End Date
July 2 2025
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moscow City Hospital named after A.K. Eramishantsev
Moscow, Russia